Global MedTech Investor Directory

One of the world's largest dedicated healthcare investment firms, managing over $20 billion across public and private equity. Backs companies at all stages from seed through large-cap public, with offices in New York, San Francisco, London, Shanghai, and Mumbai.

One of the world's largest and most active VC firms, managing over $25 billion. Healthcare is a core focus, with 2,000+ investments across digital health, MedTech, biotech, and healthcare services from seed through IPO.

A leading investor in biotechnology and medical devices, known for helping entrepreneurs with groundbreaking ideas from inception to exit. Founded in 1999 with offices across the US, Canada, and Europe.

A global multi-stage VC operating HAX and IndieBio accelerator programs, both with a strong emphasis on human and planetary health including medical devices. Active across five continents since 1995.

A healthcare investment firm managing over $15 billion in assets, supporting a diverse portfolio spanning therapeutics, medical devices, diagnostics, and digital health across private and public markets.

A global healthcare investment firm specialising in biotechnology and medical devices, employing venture capital, private equity, and public equity strategies. Strong focus on US-China cross-border healthcare investments since 1997.

A life science VC specialising in early-stage biopharma, drug delivery, and life science instruments. Manages over $1.2 billion with a hands-on company-building approach and its 4:59 Initiative for academic proof-of-concept.

Known for its hands-on approach, Third Rock creates and invests in life science companies from the ground up, bringing together scientific founders, clinical experts, and venture team members under one roof.

A Midwest-based healthcare VC investing in medical devices, life science tools, diagnostics, and tech-enabled care delivery. Emphasises capital-efficient opportunities in under-ventured US geographies with a hands-on approach.

Founded in 1969 as the Rockefeller family's venture arm, Venrock has a strong history of investing in diagnostics, medical devices, and therapeutics. Takes a long-term investment approach to scaling innovative healthcare solutions.

A bold VC backing transformative technologies including medical devices, diagnostics, and digital health. Known for high-conviction bets on early-stage innovations with potential to revolutionise patient care.

The venture capital arm of Alphabet Inc., with a dedicated healthcare division backing medical devices, diagnostics, therapeutics, and health tech. Known for its data-driven approach and founder-support resources.

A multi-stage investment firm specialising in evidence-based healthcare investing, guiding companies from inception through commercialisation. Focuses on medical devices, diagnostics, therapeutics, and research tools.

A healthcare VC specialising in venture growth investments targeting companies aiming to improve clinical outcomes, enhance patient quality of life, and reduce healthcare costs. Flexible investment structures from seed to public markets.

Exclusively dedicated to medical technology, Vensana backs development and commercial-stage companies across devices, diagnostics, data science, drug delivery, and digital health. Approximately $1 billion under management.

A diversified venture and growth equity firm managing $15.5 billion, with a strong healthcare focus spanning medical devices, diagnostics, and digital health. Backs early to mid-stage companies globally.

A VC firm investing in innovative life sciences and medical technology companies, providing strategic guidance and operational resources to help MedTech innovations reach the market from early to growth stage.

A VC firm investing in innovative life sciences and medical technology companies across US and Europe. Focuses on medical devices, diagnostics, and digital health alongside therapeutics to improve patient care.

A major VC force in digital health through its Health Assurance Fund, backing companies transforming the healthcare system. Founded in 2000 with offices in Boston, Palo Alto, San Francisco, and New York.

One of Silicon Valley's most storied VC firms, with a long history of investing in life sciences including MedTech. Founded in 1972, KP continues to back transformative digital health and medical innovation.

A major force in health tech through its Bio + Health Fund, investing in companies at the intersection of biology, health, and technology. Particularly active in AI-enabled diagnostics, digital therapeutics, and precision medicine.

A top-tier firm providing seed and early-stage funding to life sciences, physical sciences, and IT companies. Founded in 1986, ARCH specialises in spinning out innovations from universities and national labs.

A leading European life sciences VC founded in 1972, with offices in Paris, London, and Milan. Specialises in healthcare and sustainability, acting as founding investor in early-stage biopharma and MedTech start-ups.

The corporate venture arm of Medtronic, the world's largest medical device company. Invests strategically in startups aligning with Medtronic's interests across cardiovascular, neuromodulation, surgical, and diabetes technologies.

The venture capital subsidiary of Johnson & Johnson, actively investing globally in healthcare and medical device startups since 1973. One of the most active CVCs in MedTech with a global network of innovation centres.

A life sciences VC focused on investments in biotechnology, medical devices, and diagnostics. Part of EQT Group, one of Europe's leading alternative investment firms. Active across Europe and North America.

A specialised healthcare investor founded in 1982 with offices in Utrecht, Frankfurt, and Cambridge (US). Invests across medical devices, digital health, and therapeutics across Europe and North America.

A global VC with a strong focus on life sciences and medical devices. Founded in 1986 with offices in Cambridge, London, and Hong Kong, providing expertise spanning US, European, and Asian markets.

A firm focused exclusively on MedTech and biotech, partnering with life sciences companies at all stages of growth. Founded in 2012, Lightstone has offices in Boston, Portola Valley, and Dublin, Ireland.

The venture capital arm of Fidelity Investments, investing globally in seed through growth-stage technology and healthcare companies. Founded in 1969, active across digital health, MedTech, and genomics.

An early-stage VC specialising in life sciences including biopharmaceuticals, medical devices, diagnostics, and healthcare IT. Manages over $900 million with strong ties to the Research Triangle Park ecosystem.

A VC firm investing in innovative life science products and technologies, including medical devices. Founded in 1994, focused on helping early-stage MedTech ventures advance from concept to commercial-ready products.

A leading early-stage VC managing $5 billion, investing in transformative healthcare and technology companies. Active in MedTech and digital health with offices in Menlo Park, New York, and Tel Aviv.

A private equity firm specialising in US commercial-stage healthtech investments. Focuses on lower middle-market medical devices, diagnostics, digital health, and tech-enabled services. Has deployed over $400 million since 2009.

A venture firm supporting companies in cardiovascular and cerebrovascular innovation. Backed by AHA and Heart Valve Society, Broadview has a strong focus on structural heart and neurovascular medical device companies.

An Irish venture capital firm specialising in early-stage life sciences companies across Europe and the United States. Focuses on specialty pharmaceuticals, biotechnology, and medical devices with active portfolio management.

A European VC investing in innovative life science companies including medical devices and digital health. Founded in 2007 and headquartered in Luxembourg, active across Europe with a focus on clinically validated technologies.

A VC firm with over $5 billion in committed capital, specialising in early-stage healthcare and technology investments. Strong MedTech focus including medical devices, diagnostics, and digital health solutions.

An early-stage VC specialising in transformative medical technologies. Invests in therapeutic medical devices, diagnostics, and digital health addressing significant clinical needs with potential for meaningful market impact.

One of the oldest VC firms dedicated to building biomedical companies. Invests in therapeutics, biologics, drug delivery, medical devices, diagnostics, and digital health with a deeply active management approach.

A PE firm exclusively focused on the musculoskeletal healthcare sector, with over $800 million in institutional capital. Specialises in orthopedics, dental, maxillofacial, rehabilitation, and digital health industries.

The strategic venture capital arm of Merck KGaA, investing globally in transformative life science and healthcare technologies. Active in 7+ countries across the US, Europe, Israel, and Asia.

An early-stage VC focused on building the connected, consumer-centric healthcare ecosystem. Invests in digital health platforms, AI-enabled tools, and MedTech startups empowering patients and improving care delivery.

A global multi-stage VC with an expanding healthcare portfolio, focusing on tech-enabled medical solutions and health AI. Manages $25+ billion across offices in the US, Europe, India, and China.

A VC firm specialising in early-stage medical devices and biopharmaceuticals, often founding and guiding companies from inception. Focuses on products with a clear path to clinical approval addressing significant unmet needs.

A St. Louis-based VC investing in early-stage life sciences, health technology, and therapeutics. Provides strategic guidance and leverages an extensive Midwest network to facilitate portfolio company growth.

A VC focused on medical technology, diagnostics, and digital health, investing in companies with breakthrough innovations that can improve healthcare delivery and patient outcomes. Based in Redwood City, California.

A global PE and VC firm investing in the healthcare sector including medical devices and health technology. Founded in 1989 and headquartered in Chicago with investment activity across US and Europe.

A firm with over 35 years of history investing exclusively in medical devices. Headquartered in Summit, New Jersey, The Vertical Group provides deep sector expertise and extensive industry relationships.

A specialised VC investing in biotech, MedTech, and health tech companies. Founded in 2006 and based in Austin, Texas, with deep clinical and operational expertise to support portfolio companies from seed to exit.

One of the oldest healthcare-focused VCs, founded in 1985 and based in Princeton. Domain Associates invests exclusively in biopharma, device, and diagnostic companies across all stages of development.

A health system-affiliated VC investing in digital health, life sciences, and healthcare services. Affiliated with Ascension health system, providing unique access to clinical insights and real-world validation opportunities.

An accelerator and investor providing a gateway to the world's largest medical complex. Backed by 60+ institutions, offering MedTech startups access to clinicians, researchers, and the TMC innovation ecosystem in Houston.

A VC fund specifically focused on medical device venture capital, often investing at an early stage in breakthrough device technologies. Founded in 2014 and based in Grand Rapids, Michigan.

A VC firm exclusively focused on investing in companies developing leading-edge medical technologies. Founded in 1999 and based in Virginia, with a concentrated focus on medical devices and MedTech innovation.

A long-standing VC specialising in early-stage life sciences companies in therapeutics, diagnostics, medical devices, and healthcare technologies. Based in Cambridge, Massachusetts, near major academic medical centres.

A Midwest VC specialising in early-stage healthcare and technology companies, with a strong focus on medical devices and diagnostics. Leverages proximity to top research universities including University of Wisconsin–Madison.

The investment arm of BioSTL, investing in over 130 early-stage companies addressing human health and agriculture. Deep integration with Washington University in St. Louis and the regional bioscience ecosystem.

A Chicago-based early-stage VC with a notable focus on healthcare technology, supporting innovations in medical devices, diagnostics, and digital health solutions with hands-on strategic guidance.

A venture growth equity firm dedicated to transforming healthcare through investments in medical devices, health technology, and services. Focuses on expansion-stage companies with disciplined, research-driven approaches.

A VC specialising in FemTech, women's health, and MedTech. The pioneer behind the first FemTech Fund (2018), with 45+ investments including Maven Clinic and Everly Health, driving innovation in underserved health areas.

An early-stage healthcare VC with an extensive network of healthcare industry professionals. Focuses on medical technology, diagnostics, and digital health solutions with strong strategic support for portfolio companies.

A VC founded by Bill Maris (original CEO of Google Ventures) investing at the frontiers of technology and healthcare, including AI, quantum computing, and biotechnology. Founder-centric with a long-term investment thesis.

A VC democratising access to private market investments for accredited individual investors. Its Healthtech Fund supports early to growth-stage companies in medical devices, diagnostics, and AI-driven care solutions.

A seed-stage VC investing in frontier technologies including longevity, life sciences, and medical devices. Committed to supporting mission-driven entrepreneurs developing transformative innovations in healthcare.

A global VC and accelerator operating programs connecting startups with corporate partners to foster MedTech innovation. Extensive network spanning US, Europe, and Asia with strong access to strategic partnerships.

A seed-stage VC investing in transformative life sciences and digital health companies in the Cincinnati region. Collaborates with Cincinnati Children's Hospital and University of Cincinnati to commercialise healthcare innovations.

An early-stage VC investing in life sciences and medical technology companies. Provides hands-on guidance to help entrepreneurs bring MedTech innovations to market including diagnostics, medical devices, and health technologies.

A pre-seed, seed, and early-stage investor with a strong track record funding high-growth medical device startups. Founded in 2007 in Memphis, Tennessee, with deep connections to regional medical research institutions.

A life sciences-focused VC investing in companies leveraging molecular information to drive healthcare innovation including MedTech, biotechnology, and synthetic biology. Known for patience, persistence, and deep relationships.

An early-stage VC specialising in healthcare IT and medical device companies with established customer bases. Takes an active involvement approach to portfolio companies, providing strategic guidance and growth capital.

A seed-stage VC investing in software, life sciences, and deep tech with a focus on neuroscience, AI-enabled platforms, and digital healthcare. Known for founder-friendly approach and rapid decision-making.

A growth-stage and venture debt provider offering senior secured term loans to MedTech, diagnostics, and biotech firms as an alternative to equity capital. Helps companies extend runway and commercialise without excessive dilution.

A VC investing in early-stage medical device, diagnostic, and healthtech startups. Founded in 2016 and based in the San Francisco Bay Area, with a focus on clinically meaningful innovations at the device-digital intersection.

A VC and startup studio specialising in early-stage healthcare and MedTech investments. Physician-led team focusing on digital health, value-based care, and life sciences to improve healthcare quality, cost, and access.

An early-growth VC combining capital with strategic access to 500,000+ product managers through the Products That Count platform. Active in health AI and medical technology, accelerating go-to-market strategies for portfolio companies.

A VC firm specialising in early-stage biotechnology, healthcare, and life sciences investments. Partners with visionary founder teams to accelerate the development of transformative technologies addressing unmet medical needs.

A VC focused on companies addressing unmet health and economic needs. Founded in 2005 and based in Michigan, invests in MedTech and biotechnology companies with compelling clinical and commercial prospects.

An investment firm providing growth capital to life sciences and healthcare companies, including medical devices. Founded in 1971 and based in Boston, one of the longest-standing dedicated healthcare investors.

An early-stage VC focused on technology companies including life sciences and robotics. Founded in 2012 in Memphis, Tennessee, with strong regional ties and a focus on disruptive healthcare technology companies.

A VC investing exclusively in life sciences including early-stage biopharma, medical devices, digital health, and diagnostics. Founded in 2015 and based in Chattanooga, Tennessee, with a focus on transformative technologies.

One of Europe's leading life sciences VCs, founded in 1997 and managing over €1 billion. A major investor in the French and broader European MedTech and digital health ecosystem, with strong corporate and institutional backing.

A healthcare-focused VC investing from early to late stages in biotech, MedTech, and digital health across Europe. Strong foundation in the Benelux region with a focus on clinically validated, high-impact innovations.

A leading European biotech and MedTech fund with a broad focus, backing transformative innovations from early to growth stage. One of the most active life sciences VCs in Europe with US market reach.

A European deep tech VC with investments in 150+ science and tech startups across Europe. Active across energy, computing, and health, backing innovative medical device, cellular treatment, and digital health companies.

An impact-driven VC supporting HealthTech and MedTech startups tackling sustainability and AI-driven care across DACH and Northern Europe. Focuses on innovations with measurable social and environmental outcomes.

One of Europe's most prominent VCs with offices in London and San Francisco. Active in health tech and MedTech, particularly AI-enabled diagnostics and digital health platforms bridging European and US markets.

A Swiss VC investing in deep tech and digital health startups across Europe and the US. Active in MedTech and health AI, with a strong network across Switzerland's life sciences and technology ecosystem.

A global investment firm managing over $8 billion, with a major healthcare portfolio spanning healthtech, biotech, MedTech, and digital health. Active across US, Europe, and Asia with a transformative company focus.

A growth equity firm focused on healthcare IT and digital health companies. Invests in high-growth businesses transforming how healthcare is delivered, managed, and financed, including MedTech-adjacent technology platforms.

A leading healthcare-focused VC backing companies redefining how care is accessed, delivered, and financed. Active in digital health and MedTech with strong connections to health systems and payer organisations.

The first dedicated digital health fund, backing startups at the intersection of healthcare and technology. Also publishes authoritative market research and tracks digital health funding trends globally.

A global health innovation company that has invested in 400+ health moonshot companies across the world. Provides long-term support, coaching, and connections to build transformative health businesses at scale.

A VC focused on healthcare IT and services companies that improve the quality and efficiency of healthcare delivery. Active in digital health and MedTech software platforms with a focus on US payer and provider markets.

A venture debt firm providing capital to life sciences and healthcare companies. Offers senior secured term loans to MedTech, diagnostics, and biotech companies as a non-dilutive alternative for commercialisation and growth.

One of the world's oldest and most successful VC firms, with a dedicated healthcare portfolio spanning digital health, MedTech, and biotech. Active globally across the US, India, Israel, and Europe.

A premier growth equity firm focused on healthcare IT and fintech. Backs high-growth companies transforming healthcare through technology, including MedTech software platforms, digital health, and care delivery innovations.

A VC investing in emerging science and technology including life sciences and MedTech. Known for backing breakthrough healthcare innovations at the intersection of biology, physics, and computation.

The investment and holding company of the Novo Nordisk Foundation, managing assets of over DKK 900 billion. A major global investor in life sciences and MedTech through its venture, growth, and principal investment arms.

UK-based VC managing c.£1 billion across healthcare, B2B software, and deep tech. Invests from seed through Series B with a dedicated HealthTech Hub. Portfolio includes Oviva (Europe's leading virtual clinic for weight-related diseases) and Phasecraft. Founded 1996.

Europe's leading VC focused exclusively on backing European-founded tech companies. Eight funds totalling $3bn+. Invests at seed and early-growth stage across HealthTech, fintech, AI, and deep tech. Portfolio includes Revolut, Wayve, Darktrace, and GoCardless.

One of the UK’s most active investors in growing businesses. Provides patient, long-term equity capital (£1m–£10m+) to ambitious UK and Ireland companies including health tech, diagnostics, and medical devices. Backed by five major UK banks.

London-based EIS and VCT specialist investing in UK SMEs with significant health tech and life sciences exposure. Provides tax-efficient investment opportunities in innovative early-stage companies. Award-winning fund manager with over 20 years’ experience.

Specialist digital health VC backing scalable companies from seed to Series A across the UK and Europe. Focus on early-stage digital health solutions with proven clinical value. Invests across the UK, Germany, France, Spain, and Netherlands.

London-based VC leading Series A rounds ($7–10M) at the intersection of insurance, health, and technology. Portfolio spans digital health, employee benefits, cybersecurity, and connected health platforms. FCA authorised, registered in London EC2A.

UK-listed infrastructure and private equity investment manager with a health tech investment arm. Invests across sustainable technologies and health innovation in the UK, Ireland, and Spain. Manages VCT and EIS funds with significant health sector allocation.

Impact-led VC connecting global investors with world-class university innovations. Manages the UK Innovation and Science Seed Fund (UKI2S) with £110m AUM. Invests across health tech, climate tech, and deep tech. Over 70 portfolio companies with £1bn+ in follow-on co-investment.

FTSE-listed IP commercialisation company partnering with 20+ UK and international universities. Invests in deep tech, life sciences, and healthcare from inception through commercialisation. Parent company of Parkwalk Advisors. Significant portfolio of MedTech and biotech companies.

London-based VC with an equitable venture model that gives founders a stake in the fund. Invests at seed and Series A across software, AI, and health tech. Portfolio spans the UK and Europe, with a commitment to building diverse, founder-first companies.

One of Europe’s largest VCs (formerly Draper Esprit), publicly listed on the London Stock Exchange. Invests in high-growth technology companies including health tech, deeptech, and consumer. Manages EIS and VCT funds. Significant pan-European portfolio.

Venture and innovation investment arm of Nesta, the UK’s leading innovation foundation. Backs mission-driven technology including digital health, edtech, and social impact ventures. Combines grant funding with equity investment to support early-stage UK innovators.

EIS-focused investment arm of Newable, supporting high-growth UK SMEs. Invests in health tech and technology-enabled businesses at early stage. Provides hands-on support alongside capital to help founders scale.

One of Europe’s largest VCs with a substantial health tech portfolio. Invests from seed through growth stage across health, fintech, and deep tech. Part of Octopus Group. Manages EIS and VCT funds. Pan-European focus with strong UK base.

The UK’s most active investor in university spinouts, having backed 200+ companies since 2009. Specialist EIS fund manager investing in MedTech, Digital Health, Life Sciences, and Deep Tech from UK universities. Part of IP Group plc. Winner of Best EIS Investment Manager 2025.

London-based specialist investor in health tech and enterprise technology. Backs UK companies developing innovative healthcare and digital health solutions. Provides equity capital and strategic support to founders building scalable businesses.

London-based health tech and technology investor supporting UK innovation. Focuses on early-stage companies developing solutions at the intersection of health and technology. Provides equity investment and active portfolio support to UK founders.

The UK’s most active early-stage SEIS and EIS investor, having backed 500+ UK startups. Health tech is among key investment sectors. Manages SEIS funds and provides follow-on EIS capital. Invests from pre-seed stage.

Specialist healthcare investment firm with $4bn+ in historical commitments and a 30-year track record. Invests across Therapeutics (biotech, dementia), Healthcare Growth equity, and MedTech. London office at 71 Kingsway; also Boston. Portfolio includes 75+ IPOs and acquisitions.

FTSE-listed life science investment company that founds, builds, and funds global healthcare businesses from the UK. Specialises in gene therapy, cell therapy, and biotechnology. Invests patient, long-term capital in transformational healthcare companies addressing high unmet needs.

Specialist IoT and connected devices investor. Backs companies using IoT, AI, and connected technology to transform digital health, enterprise, and consumer markets. London-listed, AIM-traded investment company with a growing health portfolio.

One of the UK’s largest pre-seed+ funds with £110m AUM, managed by Future Planet Capital. Impact-first investor in engineering biology, healthcare, defence & security, space, and fusion. 70+ companies backed; £1bn+ catalysed in follow-on co-investment.

Patient capital investor affiliated with the University of Cambridge. Backs pioneering spinouts in biotechnology, MedTech, and deep tech from Cambridge and beyond. Provides long-term capital to support companies from inception through scale. Close partner of Cambridge Enterprise.

UK’s leading co-investment platform connecting individual investors with institutional-quality deal flow. Health tech is a key investment sector. EIS and SEIS eligible deals across Cambridge and nationwide.

Oxford-based EIS and growth capital investor with a strong digital health and software focus. Backs companies spun out from the Oxford ecosystem and beyond. Managed funds include EIS and VCT structures. Works closely with Oxford University Innovation.

Oxford-based specialist investment firm focusing on deep tech and science-based innovation. Works with spin-outs and companies emerging from Oxford’s world-class research base. Provides early-stage capital and strategic guidance to deep-tech founders.

Independent investment company and venture builder uniquely partnered with the University of Oxford. Builds transformational ventures across Life Sciences, HealthTech, and Deep Tech. 50+ flagship companies, £1.3bn net asset value, £3bn+ invested alongside 300+ co-investors.

Oxford-based VC specialising in early-stage deep tech and MedTech. Has managed five Oxford Technology funds, investing in science and engineering companies. Hands-on investor with direct access to Oxford’s research ecosystem and academic networks.

Midlands-focused VC specialising in MedTech and digital health investment. Also manages the GM&C Life Sciences Fund for the Greater Manchester and Cheshire region. Provides early-stage capital to innovative healthcare companies across England’s Midlands and Northern regions.

Chester-based EIS and SEIS specialist investing in UK innovation including MedTech, digital health, and life sciences. HMRC-approved fund manager enabling cutting-edge healthcare companies to reach commercialisation through tax-efficient investment structures.

Bristol-based deep tech and advanced science VC. Partners with UK researchers and entrepreneurs building breakthrough technologies with real-world impact, including healthcare applications. Supports founders with capital and hands-on operational expertise.

Dedicated life sciences fund for the Greater Manchester and Cheshire region. Invests in early-stage MedTech and biotech companies to strengthen the Northwest’s health innovation ecosystem. Managed by Catapult Ventures, one of the Midlands’ most active regional VCs.

Specialist technology-focused VC investor managing over £1.5bn AUM. EIS and VCT funds with strong MedTech and digital health portfolio. Invests in technology companies across UK regions, with a particular focus on the Midlands, North, and Scotland.

Regional growth capital provider managing the Northern Powerhouse Investment Fund, Midlands Engine Investment Fund, and other regional programmes. Invests in high-potential businesses across UK regions including health tech and digital health companies.

North East England’s leading VC, managing the North East Innovation Fund. Invests in high-growth companies in MedTech, digital health, and software. Supports ambitious founders building scalable businesses in the North East and beyond.

Manchester-based VC investing in ambitious growth businesses across the North of England. Invests £500k–£5m+ in health tech, software, and B2B companies. Provides hands-on support including introductions, recruitment, and access to the broader Praetura Group network.

The UK government’s innovation agency, part of UK Research and Innovation (UKRI). Provides grant funding, equity investment (via the British Business Bank), loans, and business support to UK companies innovating in health tech, MedTech, and life sciences.

Glasgow-based angel investment network focused on early-stage technology and health companies. Connects Scottish entrepreneurs with high-net-worth investors. Supports innovative startups in health tech with patient early-stage capital and strategic angel expertise.

Scotland’s longest-established and most active angel investment group, founded in 1992. Invests in early-stage technology, life sciences, and MedTech companies, primarily in Scotland. Has invested in 100+ companies and deployed over £80m. Strong healthcare and biotech portfolio.

Specialist life science VC with offices in Edinburgh and Bethesda, MD. Invests across the full spectrum of life sciences including biotechnology, drug development, MedTech, and diagnostics. Focus on early-stage companies in the UK and USA addressing high unmet medical need.

Glasgow-based VC investing in early-stage technology companies across Scotland and the UK. Health tech and fintech focus. Invests alongside co-investors to support ambitious Scottish founders building scalable, technology-led businesses.

Scotland’s main economic development agency. Provides investment and support to Scottish businesses including health technology, through the Scottish Investment Bank and various co-investment funds. Works alongside Highlands & Islands Enterprise to support all of Scotland.

The investment arm of Scottish Enterprise and Highlands & Islands Enterprise. Provides equity and loan finance to Scottish SMEs and co-invests alongside private funds. Health tech is among its key investment sectors. Manages the Scottish Co-Investment Fund.

Scotland-based social impact investor managing debt and equity funds. Invests in organisations tackling social challenges including health and wellbeing. Focuses on businesses delivering measurable social impact alongside financial returns. Part of Social Investment Scotland.

The Welsh Government’s investment arm, providing patient finance to Welsh businesses across all sectors including health technology. Offers flexible equity, loans, and mezzanine finance. Mission-driven to support economic growth across Wales with sector-agnostic investment.

Ulster University’s technology transfer and commercialisation company. Supports health tech and life sciences spinouts emerging from Ulster’s research base. Provides IP licensing, spinout creation, and early-stage investment support to innovative Northern Ireland companies.

Queen’s University Belfast’s commercialisation and investment company. Invests in and supports health tech, life sciences, and science-based spinouts from Queen’s University. A key player in Northern Ireland’s innovation ecosystem, backed by UKRI and Invest NI.

Growth equity arm of Gresham House Asset Management. Invests £1m–£20m in high-growth UK businesses, with 200+ investments over 20 years and £200m capital to deploy. Sectors include HealthTech, AI, cybersecurity, fintech, and enterprise software. Portfolio includes Orri (digital healthcare) and Metrion Biosciences.

Early-stage UK VC backing founders creating positive system change across Health, Life, and Sustainability. Health portfolio spans preventative care, digital physiotherapy, pelvic health, endometriosis diagnostics, and AI-powered surgical intelligence. B Corp certified. FCA authorised.

Ireland’s primary government agency for backing Irish MedTech and health tech startups into global markets. The Pre-Seed Start Fund (PSSF) provides €50k (standard) or €100k (competitive) for early-stage concept validation. The High Potential Start-Up (HPSU) Fund co-invests up to €800,000 (exceptionally €1m) in startups with globally scalable products. In 2025, Enterprise Ireland invested €32.9 million across 198 Irish startups. Also provides MedTech-specific R&D feasibility studies and market development support.

Ireland’s sovereign development fund, managed by the National Treasury Management Agency (NTMA) with a mandate to invest on a commercial basis in a manner designed to support economic activity and employment in Ireland. Manages €8.6bn+ in assets and invests across healthcare, life sciences, technology, and infrastructure. Co-invests alongside private capital in high-growth Irish companies.

A leading European venture capital firm specialising in early-to-growth stage biotech and MedTech, founded in 2002 and headquartered in Dublin. Hands-on life sciences builder taking concentrated positions with active portfolio support from inception through clinical evaluation to market launch. Fund IV closed at €123 million in 2024. Portfolio includes Perfuze (neurovascular), Deciphex (AI pathology), Complement Therapeutics, and Sibylla Biotech. Regularly co-invests with Enterprise Ireland at HPSU stage.

Dublin-based seed-to-Series A fund built on Furthr’s 35-year heritage (formerly DBIC) supporting over 7,000 Irish startups. Current €32 million fund invests in globally scalable Irish software and MedTech companies. Strong track record in health tech — portfolio includes SilverCloud (digital mental health, acquired by Spring Health), Bluedrop Medical (diabetes devices), and NeuroBell (neurology, €2.1m seed). Also operates the Furthr Foundry pre-seed accelerator.

Ireland’s leading full-service investment firm, providing corporate finance, capital markets, and wealth management services. Goodbody’s corporate finance team advises life sciences and MedTech companies on fundraising, M&A, and capital markets transactions including IPOs on Euronext Dublin and AIM. A key institutional partner for Irish MedTech companies seeking growth capital and exit strategies.